Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Announcement of joint research agreement with Mie University for the development of new drugs for lifestyle-related diseases targeting our compounds
Announcement of the commencement of joint research on next-generation drug development for the creation of new eye disease treatments
FDA Acceptance of New Drug Application for DW-5LBT
Corporate Governance Report March 25,2025
D.Western Therapeutics Institute, The Current Fiscal Year's Net Income to Narrow
FY12/24 Financial Results Briefing Materials
Consolidated Financial Results for the Fiscal Year Ended December 31, 2024 (Based on Japanese GAAP)
D.Western Therapeutics Institute, Last Fiscal Year Net Income Loss to Narrow
D.Western Therapeutics Institute, Inc., January-September (Third Quarter Cumulative) Net Income Loss Widens, July-September Net Income Loss Widens
Consolidated Financial Results for the Nine Months Ended September 30, 2024 (Based on Japanese GAAP)